Table 2 The compliance before, 6, 12, and 24 months after the implementation of clinical guidelines for depression in % (n).
From: Supported local implementation of clinical guidelines in psychiatry: a two-year follow-up
Implementation clinics | Control clinics | |||
|---|---|---|---|---|
Indicator | % (n) | OR (95% CI) | % (n) | OR (95% CI) |
Accessibility/wait time | ||||
0 months | 77.9 (95) | reference | 59.0 (36) | reference |
6 months | 89.2 (107) | 2.4 (1.1-5.2) | 53.3 (32) | 0.6 (0.3-1.4) |
12 months | 97.1 (233) | 13.4 (5.3-34.0) | 44.2 (53) | 0.4 (0.2-0.9) |
24 months | 90.0 (216) | 2.5 (1.3-4.9) | 51.7 (62) | 0.6 (0.3-1.2) |
Diagnostic assessment | ||||
0 months | 83.6 (102) | reference | 88.5 (54) | reference |
6 months | 97.5 (117) | 9.6 (2.5-36.1) | 90.0 (54) | 1.1 (0.4-3.6) |
12 months | 97.5 (234) | 11.1 (4.0-30.9) | 83.3 (100) | 0.6 (0.3-1.6) |
24 months | 97.9 (235) | 10.9 (3.7-32.4) | 79.2 (95) | 0.5 (0.2-1.2) |
Diagnostic instrument | ||||
0 months | 12.3 (15) | reference | 1.6 (1) | reference |
6 months | 28.3 (34) | 2.8 (1.4-5.5) | 0 | na |
12 months | 41.3 (99) | 5.3 (2.9-9.7) | 0.8 (1) | na |
24 months | 44.2 (106) | 5.7 (3.1-10.5) | 0.8 (1) | na |
Standardized rating scale | ||||
0 months | 64.8 (79) | reference | 44.3 (27) | reference |
6 months | 91.7 (110) | 6.2 (2.9-13.3) | 33.3 (20) | 0.7 (0.3-1.4) |
12 months | 95.0 (228) | 11.1 (5.5-22.3) | 37.5 (45) | 0.8 (0.4-1.5) |
24 months | 94.2 (226) | 9.1 (4.7-17.6) | 36.7 (44) | 0.7 (0.4-1.4) |
Standardized rating scale during treatment | ||||
0 months | 50.0 (61) | reference | 24.6 (15) | reference |
6 months | 87.5 (105) | 7.6 (3.9-14.9) | 38.3 (23) | 1.9 (0.8-4.2) |
12 months | 97.5 (234) | 47.5 (19.0-118.2) | 30.8 (37) | 1.4 (0.7-2.8) |
24 months | 88.3 (212) | 8.1 (4.7-14.3) | 33.3 (40) | 1.5 (0.8-3.1) |
Substance/drug abuse | ||||
0 months | 46.7 (57) | reference | 32.8 (20) | reference |
6 months | 87.5 (105) | 8.0 (4.2-15.4) | 53.2 (32) | 2.8 (1.3-6.2) |
12 months | 94.2 (226) | 18.5 (9.7-35.4) | 35.0 (42) | 1.2 (0.6-2.3) |
24 months | 88.8 (213) | 9.1 (5.3-15.6) | 43.3 (52) | 1.8 (0.9-3.6) |
Treatment (care) plan | ||||
0 months | 59.8 (73) | reference | 42.6 (26) | reference |
6 months | 87.5 (105) | 5.5 (2.7-11.1) | 38.3 (23) | 0.9(0.4-1.9) |
12 months | 90.4 (217) | 8.4 (4.5-15.5) | 34.2 (41) | 0.7 (0.4-1.4) |
24 months | 91.3 (219) | 8.1 (4.3-15.0) | 27.5 (33) | 0.5 (0.3-1.0) |
Evaluation/outcome | ||||
0 months | 66.4 (81) | reference | 59.0 (36) | reference |
6 months | 95.8 (115) | 11.9 (4.5-31.7) | 55.0 (33) | 0.8 (0.4-1.7) |
12 months | 97.5 (234) | 20.3 (8.2-49.9) | 48.3 (58) | 0.6 (0.3-1.1) |
24 months | 95.8 (230) | 11.9 (5.7-25.0) | 48.3 (58) | 0.6 (0.3-1.1) |
Continuity | ||||
0 months | 77.0 (94) | reference | 78.7 (48) | reference |
6 months | 95.0 (114) | 5.6 (2.2-14.1) | 61.7 (37) | 0.4 (0.2-1.1) |
12 months | 99.6 (239) | 72.0 (9.7-537.4) | 71.7 (86) | 0.7 (0.3-1.5) |
24 months | 95.8 (230) | 6.7 (3.1-14.4) | 68.3 (82) | 0.6 (0.3-1.4) |
Suicide assessment | ||||
0 months | 40.2 (49) | reference | 45.9 (28) | reference |
6 months | 95.8 (115) | 36.1 (13.5-96.5) | 35.0 (21) | 0.6 (0.3-1.4) |
12 months | 93.8 (225) | 23.3 (12.1-44.7) | 35.8 (43) | 0.7 (0.4-1.2) |
24 months | 97.5 (234) | 61.3 (24.8-151.9) | 30.0 (36) | 0.5 (0.3-1.0) |
Antidepressant medication | ||||
0 months | 54.1 (66) | reference | 45.9 (28) | reference |
6 months | 90.8 (109) | 8.3 (4.1-17.0) | 36.7 (22) | 0.7 (0.3-1.4) |
12 months | 85.4 (205) | 5.0 (3.0-8.2) | 44.2 (53) | 1.0 (0.5-1.7) |
24 months | 92.5 (222) | 10.3 (5.7-18.8) | 41.7 (50) | 0.8 (0.4-1.5) |